{
  "success": true,
  "pagesUsed": [
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Daratumumab",
        "type": {
          "id": "ea47d9e6-c439-4461-a5c7-da1273b98556",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "52d7adf2-a7d2-4014-baec-2ff4f60459ad",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Human IgG1κ monoclonal antibody that binds to CD38.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Lenalidomide",
        "type": {
          "id": "46ac8d8c-2674-467f-a77d-7af727f1e493",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "a8e14fe7-76d8-4ada-bae4-16567dac7ef6",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Standard of care therapy for multiple myeloma administered in both Arm A and Arm B.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Dexamethasone",
        "type": {
          "id": "c2282207-eb3c-48e0-8e34-614506ee5a6b",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "dcd2a2aa-e5a6-40b8-9718-76e4947329d7",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Corticosteroid administered in both Arm A and Arm B; also used as pre-dose medication.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Acetaminophen/paracetamol",
        "type": {
          "id": "4d8ccde3-a23a-419d-b968-1721d2656491",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "25d6b46d-8f04-41a4-8b75-019f4c26f74c",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Required pre-dose medication to prevent infusion-related reactions.",
        "productIds": [
          "prod_4"
        ],
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Antihistamine",
        "type": {
          "id": "fcdf61a8-f1d3-4a07-93a5-30d62dce4f07",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "83245376-485c-4b59-a52d-b1236f9e5c4f",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Required pre-dose medication (e.g., diphenhydramine) to prevent infusion-related reactions."
      },
      {
        "id": "int_6",
        "name": "Aspirin",
        "type": {
          "id": "d9a26fab-170c-4f27-84bd-e342690ecd2f",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "12324b6a-37a2-4412-bed1-e238fe808201",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Recommended prophylaxis for deep vein thrombosis and pulmonary embolism."
      },
      {
        "id": "int_7",
        "name": "Low molecular weight heparin",
        "type": {
          "id": "93cfbfb3-6816-49ea-a207-9de22276721f",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "7ce501e9-eea4-4677-99e0-43a509ce7a5f",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Recommended prophylaxis for venous thromboembolism in high-risk subjects."
      },
      {
        "id": "int_8",
        "name": "Clarithromycin",
        "type": {
          "id": "91c6c814-33e2-469c-a1f6-7a8730f4c483",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "8a31ddd1-227b-45dc-85e3-525436687718",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited therapy due to potential anti-multiple myeloma effects."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Daratumumab IV",
        "administrableDoseForm": {
          "id": "92dc588a-0b15-45c8-b5a1-95e8ba28bde3",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "3455b940-9868-43f3-b327-87d53ad5df55",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "059ba751-cf87-4539-ab10-143f6ca720e2",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "20 mg/mL",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Janssen Pharmaceutica NV"
      },
      {
        "id": "prod_2",
        "name": "Daratumumab SC",
        "administrableDoseForm": {
          "id": "841ebbd9-3c74-4c78-ac68-7244816e93df",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "3701fd06-e65e-4de9-bfb1-0260fe42bcd0",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "7fd0ed2e-8855-487a-8018-4222b519d155",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "1800 mg",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Janssen Pharmaceutica NV"
      },
      {
        "id": "prod_3",
        "name": "Lenalidomide",
        "administrableDoseForm": {
          "id": "c6058abb-9afa-4461-8589-226959e93d3b",
          "code": "C25158",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Capsule",
          "standardCode": {
            "id": "55603a21-fdf2-459e-bf81-6024c629254e",
            "code": "C25158",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Capsule",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "bc723291-a14b-445c-b351-96f2e7ff48cd",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "25 mg, 15 mg, 10 mg, 5 mg",
        "substanceIds": [
          "sub_3"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_4",
        "name": "Dexamethasone",
        "administrableDoseForm": {
          "id": "d2e9fbe5-5f30-411c-b372-d9c52960beaf",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "25266f5b-928d-4e4f-aab5-7e7cdfe4ef54",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "fd5a4ec7-e3e0-4564-8387-102304dc2529",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "40 mg, 20 mg",
        "substanceIds": [
          "sub_4"
        ],
        "manufacturer": "Not specified"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Daratumumab IV Regimen",
        "instanceType": "Administration",
        "dose": "16 mg/kg",
        "doseFrequency": "Weekly (C1-2), Every 2 weeks (C3-6), Every 4 weeks (C7+)",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_2",
        "name": "Daratumumab SC Regimen",
        "instanceType": "Administration",
        "dose": "1800 mg",
        "doseFrequency": "Weekly (C1-2), Every 2 weeks (C3-6), Every 4 weeks (C7+)",
        "route": {
          "code": "Subcutaneous",
          "codeSystem": "USDM",
          "decode": "Subcutaneous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_3",
        "name": "Lenalidomide Regimen",
        "instanceType": "Administration",
        "dose": "25 mg",
        "doseFrequency": "Once daily on Days 1-21 of each 28-day cycle",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_4",
        "name": "Dexamethasone Regimen",
        "instanceType": "Administration",
        "dose": "40 mg",
        "doseFrequency": "Weekly",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Daratumumab",
        "instanceType": "Substance",
        "description": "Human IgG1κ monoclonal antibody"
      },
      {
        "id": "sub_2",
        "name": "rHuPH20",
        "instanceType": "Substance",
        "description": "Recombinant human hyaluronidase PH20 (used in SC formulation)"
      },
      {
        "id": "sub_3",
        "name": "Lenalidomide",
        "instanceType": "Substance",
        "description": "Immunomodulatory imide drug (IMiD)"
      },
      {
        "id": "sub_4",
        "name": "Dexamethasone",
        "instanceType": "Substance",
        "description": "Glucocorticoid"
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "Electronic device (ePRO)",
        "instanceType": "MedicalDevice",
        "manufacturer": "Not specified"
      }
    ],
    "summary": {
      "interventionCount": 8,
      "productCount": 4,
      "deviceCount": 1
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Daratumumab",
        "role": "Investigational Product",
        "description": "Human IgG1κ monoclonal antibody that binds to CD38."
      },
      {
        "name": "Lenalidomide",
        "role": "Background Therapy",
        "description": "Standard of care therapy for multiple myeloma administered in both Arm A and Arm B."
      },
      {
        "name": "Dexamethasone",
        "role": "Background Therapy",
        "description": "Corticosteroid administered in both Arm A and Arm B; also used as pre-dose medication."
      },
      {
        "name": "Acetaminophen/paracetamol",
        "role": "Concomitant Medication",
        "description": "Required pre-dose medication to prevent infusion-related reactions."
      },
      {
        "name": "Antihistamine",
        "role": "Concomitant Medication",
        "description": "Required pre-dose medication (e.g., diphenhydramine) to prevent infusion-related reactions."
      },
      {
        "name": "Aspirin",
        "role": "Concomitant Medication",
        "description": "Recommended prophylaxis for deep vein thrombosis and pulmonary embolism."
      },
      {
        "name": "Low molecular weight heparin",
        "role": "Concomitant Medication",
        "description": "Recommended prophylaxis for venous thromboembolism in high-risk subjects."
      },
      {
        "name": "Clarithromycin",
        "role": "Concomitant Medication",
        "description": "Prohibited therapy due to potential anti-multiple myeloma effects."
      }
    ],
    "products": [
      {
        "name": "Daratumumab IV",
        "doseForm": "Solution",
        "strength": "20 mg/mL",
        "manufacturer": "Janssen Pharmaceutica NV"
      },
      {
        "name": "Daratumumab SC",
        "doseForm": "Injection",
        "strength": "1800 mg",
        "manufacturer": "Janssen Pharmaceutica NV"
      },
      {
        "name": "Lenalidomide",
        "doseForm": "Capsule",
        "strength": "25 mg, 15 mg, 10 mg, 5 mg",
        "manufacturer": "Not specified"
      },
      {
        "name": "Dexamethasone",
        "doseForm": "Tablet",
        "strength": "40 mg, 20 mg",
        "manufacturer": "Not specified"
      }
    ],
    "substances": [
      {
        "name": "Daratumumab",
        "description": "Human IgG1κ monoclonal antibody"
      },
      {
        "name": "rHuPH20",
        "description": "Recombinant human hyaluronidase PH20 (used in SC formulation)"
      },
      {
        "name": "Lenalidomide",
        "description": "Immunomodulatory imide drug (IMiD)"
      },
      {
        "name": "Dexamethasone",
        "description": "Glucocorticoid"
      }
    ],
    "administrations": [
      {
        "name": "Daratumumab IV Regimen",
        "dose": "16 mg/kg",
        "frequency": "Weekly (C1-2), Every 2 weeks (C3-6), Every 4 weeks (C7+)",
        "route": "Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Daratumumab SC Regimen",
        "dose": "1800 mg",
        "frequency": "Weekly (C1-2), Every 2 weeks (C3-6), Every 4 weeks (C7+)",
        "route": "Subcutaneous",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Lenalidomide Regimen",
        "dose": "25 mg",
        "frequency": "Once daily on Days 1-21 of each 28-day cycle",
        "route": "Oral",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Dexamethasone Regimen",
        "dose": "40 mg",
        "frequency": "Weekly",
        "route": "Oral or Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      }
    ],
    "devices": [
      {
        "name": "Electronic device (ePRO)",
        "manufacturer": "Not specified",
        "purpose": "Collection of Patient Reported Outcomes"
      }
    ]
  }
}